blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3216865

EP3216865 - AMADORIASE HAVING ENHANCED ANIONIC-SURFACTANT TOLERANCE [Right-click to bookmark this link]
Former [2017/37]AMADORIASE HAVING IMPROVED ANIONIC-SURFACTANT RESISTANCE
[2020/20]
StatusNo opposition filed within time limit
Status updated on  06.08.2021
Database last updated on 19.03.2026
FormerThe patent has been granted
Status updated on  28.08.2020
FormerGrant of patent is intended
Status updated on  20.04.2020
FormerExamination is in progress
Status updated on  08.04.2020
FormerGrant of patent is intended
Status updated on  10.12.2019
FormerExamination is in progress
Status updated on  08.05.2019
FormerRequest for examination was made
Status updated on  11.08.2017
FormerThe international publication has been made
Status updated on  02.06.2017
Most recent event   Tooltip22.07.2022Lapse of the patent in a contracting state
New state(s): BE		published on 24.08.2022  [2022/34]
Applicant(s)For all designated states
Kikkoman Corporation
250, Noda
Noda-shi, Chiba 278-8601 / JP
[2017/37]
Inventor(s)01 / MASAKARI, Yosuke
c/o Kikkoman Corporation
250, Noda
Noda-shi Chiba 278-8601 / JP
02 / KOMATSUZAKI, Airi
c/o Kikkoman Corporation
250, Noda
Noda-shi Chiba 278-8601 / JP
 [2020/40]
Former [2017/37]01 / MASAKARI, Yosuke
c/o Kikkoman Corporation
250 Noda
Noda-shi Chiba 278-8601 / JP
02 / KOMATSUZAKI, Airi
c/o Kikkoman Corporation
250 Noda
Noda-shi Chiba 278-8601 / JP
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[2020/40]
Former [2017/37]Keirstead, Tanis Evelyne, et al
Mewburn Ellis LLP
City Tower
40 Basinghall Street
London EC2V 5DE / GB
Application number, filing date15856363.506.11.2015
[2017/37]
WO2015JP81410
Priority number, dateJP2014022754807.11.2014         Original published format: JP 2014227548
[2017/37]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016072520
Date:12.05.2016
Language:JA
[2016/19]
Type: A1 Application with search report 
No.:EP3216865
Date:13.09.2017
Language:EN
[2017/37]
Type: B1 Patent specification 
No.:EP3216865
Date:30.09.2020
Language:EN
[2020/40]
Search report(s)International search report - published on:JP12.05.2016
(Supplementary) European search report - dispatched on:EP25.04.2018
ClassificationIPC:C12N15/53, C12N9/02, C12Q1/26
[2018/21]
CPC:
C12N9/0032 (EP,US); C12N15/09 (US); C12Q1/26 (EP,US);
G01N33/723 (EP)
Former IPC [2017/37]C12N15/09, C12N9/06, C12Q1/26
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/37]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:AMADORIASE MIT ERHÖHTER TOLERANCE GEGENÜBER ANIONISCHEN TENSIDEN[2020/20]
English:AMADORIASE HAVING ENHANCED ANIONIC-SURFACTANT TOLERANCE[2020/20]
French:AMADORIASE AYANT UNE TOLÉRANCE ACCRUE AUX TENSIOACTIFS ANIONIQUES[2020/20]
Former [2017/37]AMADORIASE MIT VERBESSERTER RESISTENZ GEGENÜBER ANIONISCHEN TENSIDEN
Former [2017/37]AMADORIASE HAVING IMPROVED ANIONIC-SURFACTANT RESISTANCE
Former [2017/37]AMADORIASE AYANT UNE RÉSISTANCE AMÉLIORÉE AUX TENSIOACTIFS ANIONIQUES
Entry into regional phase02.06.2017Translation filed 
02.06.2017National basic fee paid 
02.06.2017Search fee paid 
02.06.2017Designation fee(s) paid 
02.06.2017Examination fee paid 
Examination procedure02.06.2017Examination requested  [2017/37]
02.06.2017Date on which the examining division has become responsible
26.11.2018Amendment by applicant (claims and/or description)
13.05.2019Despatch of a communication from the examining division (Time limit: M06)
25.11.2019Reply to a communication from the examining division
11.12.2019Communication of intention to grant the patent
07.04.2020Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
21.04.2020Communication of intention to grant the patent
20.08.2020Fee for grant paid
20.08.2020Fee for publishing/printing paid
20.08.2020Receipt of the translation of the claim(s)
Opposition(s)01.07.2021No opposition filed within time limit [2021/36]
Fees paidRenewal fee
04.09.2017Renewal fee patent year 03
23.11.2018Renewal fee patent year 04
19.11.2019Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU06.11.2015
AL30.09.2020
AT30.09.2020
CY30.09.2020
CZ30.09.2020
DK30.09.2020
EE30.09.2020
ES30.09.2020
FI30.09.2020
HR30.09.2020
IT30.09.2020
LT30.09.2020
LV30.09.2020
MC30.09.2020
MK30.09.2020
MT30.09.2020
NL30.09.2020
PL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SI30.09.2020
SK30.09.2020
SM30.09.2020
TR30.09.2020
IE06.11.2020
LU06.11.2020
BE30.11.2020
CH30.11.2020
LI30.11.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
IS30.01.2021
PT01.02.2021
[2022/34]
Former [2022/32]HU06.11.2015
AL30.09.2020
AT30.09.2020
CY30.09.2020
CZ30.09.2020
DK30.09.2020
EE30.09.2020
ES30.09.2020
FI30.09.2020
HR30.09.2020
IT30.09.2020
LT30.09.2020
LV30.09.2020
MC30.09.2020
MK30.09.2020
MT30.09.2020
NL30.09.2020
PL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SI30.09.2020
SK30.09.2020
SM30.09.2020
TR30.09.2020
IE06.11.2020
LU06.11.2020
CH30.11.2020
LI30.11.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
IS30.01.2021
PT01.02.2021
Former [2022/27]HU06.11.2015
AL30.09.2020
AT30.09.2020
CY30.09.2020
CZ30.09.2020
DK30.09.2020
EE30.09.2020
ES30.09.2020
FI30.09.2020
HR30.09.2020
IT30.09.2020
LT30.09.2020
LV30.09.2020
MC30.09.2020
MT30.09.2020
NL30.09.2020
PL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SI30.09.2020
SK30.09.2020
SM30.09.2020
TR30.09.2020
IE06.11.2020
LU06.11.2020
CH30.11.2020
LI30.11.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
IS30.01.2021
PT01.02.2021
Former [2022/23]AL30.09.2020
AT30.09.2020
CZ30.09.2020
DK30.09.2020
EE30.09.2020
ES30.09.2020
FI30.09.2020
HR30.09.2020
IT30.09.2020
LT30.09.2020
LV30.09.2020
MC30.09.2020
NL30.09.2020
PL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SI30.09.2020
SK30.09.2020
SM30.09.2020
IE06.11.2020
LU06.11.2020
CH30.11.2020
LI30.11.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
IS30.01.2021
PT01.02.2021
Former [2022/10]AL30.09.2020
AT30.09.2020
CZ30.09.2020
DK30.09.2020
EE30.09.2020
ES30.09.2020
FI30.09.2020
HR30.09.2020
IT30.09.2020
LT30.09.2020
LV30.09.2020
MC30.09.2020
NL30.09.2020
PL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SI30.09.2020
SK30.09.2020
SM30.09.2020
IE06.11.2020
LU06.11.2020
CH30.11.2020
LI30.11.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
PT01.02.2021
Former [2021/50]AL30.09.2020
AT30.09.2020
CZ30.09.2020
DK30.09.2020
EE30.09.2020
ES30.09.2020
FI30.09.2020
HR30.09.2020
IT30.09.2020
LT30.09.2020
LV30.09.2020
MC30.09.2020
NL30.09.2020
PL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SI30.09.2020
SK30.09.2020
SM30.09.2020
IE06.11.2020
LU06.11.2020
CH30.11.2020
LI30.11.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
IS30.01.2021
PT01.02.2021
Former [2021/48]AL30.09.2020
AT30.09.2020
CZ30.09.2020
DK30.09.2020
EE30.09.2020
ES30.09.2020
FI30.09.2020
HR30.09.2020
IT30.09.2020
LT30.09.2020
LV30.09.2020
MC30.09.2020
NL30.09.2020
PL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SK30.09.2020
SM30.09.2020
IE06.11.2020
LU06.11.2020
CH30.11.2020
LI30.11.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
IS30.01.2021
PT01.02.2021
Former [2021/46]AL30.09.2020
AT30.09.2020
CZ30.09.2020
DK30.09.2020
EE30.09.2020
ES30.09.2020
FI30.09.2020
HR30.09.2020
LT30.09.2020
LV30.09.2020
MC30.09.2020
NL30.09.2020
PL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SK30.09.2020
SM30.09.2020
IE06.11.2020
LU06.11.2020
CH30.11.2020
LI30.11.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
IS30.01.2021
PT01.02.2021
Former [2021/37]AL30.09.2020
AT30.09.2020
CZ30.09.2020
DK30.09.2020
EE30.09.2020
ES30.09.2020
FI30.09.2020
HR30.09.2020
LT30.09.2020
LV30.09.2020
MC30.09.2020
NL30.09.2020
PL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SK30.09.2020
SM30.09.2020
LU06.11.2020
CH30.11.2020
LI30.11.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
IS30.01.2021
PT01.02.2021
Former [2021/33]AL30.09.2020
AT30.09.2020
CZ30.09.2020
EE30.09.2020
ES30.09.2020
FI30.09.2020
HR30.09.2020
LT30.09.2020
LV30.09.2020
MC30.09.2020
NL30.09.2020
PL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SK30.09.2020
SM30.09.2020
LU06.11.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
IS30.01.2021
PT01.02.2021
Former [2021/31]AL30.09.2020
AT30.09.2020
CZ30.09.2020
EE30.09.2020
ES30.09.2020
FI30.09.2020
HR30.09.2020
LT30.09.2020
LV30.09.2020
MC30.09.2020
NL30.09.2020
PL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SK30.09.2020
SM30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
IS30.01.2021
PT01.02.2021
Former [2021/28]AL30.09.2020
AT30.09.2020
CZ30.09.2020
EE30.09.2020
ES30.09.2020
FI30.09.2020
HR30.09.2020
LT30.09.2020
LV30.09.2020
NL30.09.2020
PL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SK30.09.2020
SM30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
IS30.01.2021
PT01.02.2021
Former [2021/25]AL30.09.2020
AT30.09.2020
CZ30.09.2020
EE30.09.2020
ES30.09.2020
FI30.09.2020
HR30.09.2020
LT30.09.2020
LV30.09.2020
NL30.09.2020
PL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SM30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
IS30.01.2021
PT01.02.2021
Former [2021/23]AT30.09.2020
CZ30.09.2020
EE30.09.2020
FI30.09.2020
HR30.09.2020
LT30.09.2020
LV30.09.2020
NL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
SM30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
PT01.02.2021
Former [2021/22]CZ30.09.2020
EE30.09.2020
FI30.09.2020
HR30.09.2020
LT30.09.2020
LV30.09.2020
NL30.09.2020
RO30.09.2020
RS30.09.2020
SE30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
PT01.02.2021
Former [2021/21]FI30.09.2020
HR30.09.2020
LT30.09.2020
LV30.09.2020
NL30.09.2020
RS30.09.2020
SE30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
PT01.02.2021
Former [2021/20]FI30.09.2020
HR30.09.2020
LT30.09.2020
LV30.09.2020
RS30.09.2020
SE30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
Former [2021/10]FI30.09.2020
HR30.09.2020
LV30.09.2020
RS30.09.2020
SE30.09.2020
BG30.12.2020
NO30.12.2020
GR31.12.2020
Former [2021/08]FI30.09.2020
SE30.09.2020
BG30.12.2020
NO30.12.2020
Former [2021/07]FI30.09.2020
NO30.12.2020
Documents cited:Search[E] EP3061819  (KIKKOMAN CORP et al.) [E] 1,9-11 * the whole document *
 [E] WO2015060429  (KIKKOMAN CORP et al.) * the whole document *
International search[XA] JP2013500729   [X] 1-3, 22-26, 30 * , claim 23; SEQ ID NO:1, 7; paragraphs [0001] to [0003] & US 2012/0208226 A1 claim 23; SEQ ID NO:1, 7 & WO 2011/015326 A2 & EP 2287295 A1 & CN 102471763 A *[A] 4-21, 27-29, 31-34
 [XA] JP2010104278  (TOYO BOSEKI et al.) [X] 1, 22-26, 30 * , claim 1 (Family: none) *[A] 2-21, 27-29, 31-34
 [XY] WO2012018094  (KIKKOMAN CORP et al.) [X] 1-20, 30 * , examples 28 to 30; fig. 1 & US 2013/0267007 A1 examples 28 to 30; fig. 1 & EP 2602318 A1 & CN 103080308 A & KR 10-2013-0105614 A *[Y] 21-29, 31-34
 [XY] WO2004104203  (ASAHI KASEI PHARMA CORP et al.) [X] 1-20, 30 * , fig. 1; page 32, 6th line from the bottom to page 36, line 12 & US 2008/0113381 A1 fig. 1; paragraphs [0184] to [0198] & EP 1626088 A1 & DE 602004030328 D & CN 1823166 A & HK 1080116 A & AT 490325 T *[Y] 21-29, 31-34
 [X] JP2008201968  (ASAHI KASEI PHARMA KK et al.) [X] 1-34 * , examples 12 to 17 & US 2008/0295259 A1 examples 12 to 17 *
 [P, X] WO2015020200  (KIKKOMAN CORP et al.) [P, X] 1-3, 21-30 * , example 4 (Family: none) *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.